ShedRx vs TrimRx (2026): prices, structure, verdict

On tirzepatide, ShedRx↗ is cheaper: $289 versus $349 a month all-in — a $60 monthly gap, $720 across a year of maintenance dosing.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

On semaglutide, ShedRx is cheaper: $249 versus $299 a month all-in — a $50 monthly gap, $600 across a year of maintenance dosing.

§ Side by side

§ Each record, read aloud

The two records, condensed

ShedRx: the record, condensed

On tirzepatide, the number that matters at ShedRx is $289 a month all-in — the figure at the 10 mg maintenance basis this whole site ranks on. Pricing steps with the dose here: from $199 at entry to $289 at the 10 mg basis. Multiply the wrong one of those by twelve and your budget is off by $1,080 a year, which is why every ranking on this site uses the larger number.

Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $289 is the whole subscription, which makes ShedRx unusually easy to compare and unusually easy to leave.

To place the number: #5 of 17 verified programs, with the floor $74/month below at NexLife↗ ($215); the approved-product yardstick (Zepbound (LillyDirect↗)) sits at $449, so the compounded case here is worth $160 a month. A year at this figure: $3,468 monthly-billed.

On semaglutide, the number that matters at ShedRx is $249 a month all-in — the figure at the 2.4 mg maintenance basis this whole site ranks on. The structure is tiered: the advertised entry point is $175, but the maintenance figure — the one a full year is actually billed at — is $249. That $74 gap between the ad and the anniversary is the single most important line in this record.

Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $249 is the whole subscription, which makes ShedRx unusually easy to compare and unusually easy to leave.

Context for that figure: it ranks #13 of 20 in the verified semaglutide index — $116/month above the floor (Oak Longevity, $133) — and sits $100 under the brand benchmark (Wegovy (NovoCare↗), $349 at maintenance). Annualized, a monthly-billed year here runs $2,988.

Operationally at ShedRx: shipping included; commitment none month-to-month; cancellation 72-hour notice before the next billing cycle; pharmacy not publicly named — ask in writing before paying; states: not published; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the ShedRx page · visit ShedRx ↗

TrimRx: the record, condensed

Start with the load-bearing figure: $349 a month, all-in, is what TrimRx charges for tirzepatide at the 10 mg basis. Because pricing is flat across the ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)), a dose increase at TrimRx is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.

Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $349 is the whole subscription, which makes TrimRx unusually easy to compare and unusually easy to leave.

To place the number: #11 of 17 verified programs, with the floor $134/month below at NexLife ($215); the approved-product yardstick (Zepbound (LillyDirect)) sits at $449, so the compounded case here is worth $100 a month. A year at this figure: $4,188 monthly-billed.

Start with the load-bearing figure: $299 a month, all-in, is what TrimRx charges for semaglutide at the 2.4 mg basis. It is a flat structure: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.

Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $299 is the whole subscription, which makes TrimRx unusually easy to compare and unusually easy to leave.

Context for that figure: it ranks #17 of 20 in the verified semaglutide index — $166/month above the floor (Oak Longevity, $133) — and sits $50 under the brand benchmark (Wegovy (NovoCare), $349 at maintenance). Annualized, a monthly-billed year here runs $3,588.

Operationally at TrimRx: shipping included; commitment none month-to-month; cancellation check terms before prepaying; pharmacy not publicly named — ask in writing before paying; states: not published; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the TrimRx page · visit TrimRx ↗

Tirzepatide: the duel in full

Put the two tirzepatide figures side by side and hold them there: ShedRx at $289, TrimRx at $349 — a $60 monthly spread that compounds to $720 over a maintenance year and $1,440 over two.

Structure sharpens the gap: TrimRx’s figure is dose-flat (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available) all bill the same), while ShedRx’s is not — so TrimRx’s number is a ceiling and ShedRx’s advertised entry ($199) is a floor. Comparing a ceiling to a floor flatters the floor; this site compares maintenance to maintenance, which is the table above.

Semaglutide: the duel in full

The semaglutide arithmetic between these two is short: $249 (ShedRx) against $299 (TrimRx). $50 a month sounds survivable; $600 a year is a decision.

Structure sharpens the gap: TrimRx’s figure is dose-flat (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg all bill the same), while ShedRx’s is not — so TrimRx’s number is a ceiling and ShedRx’s advertised entry ($175) is a floor. Comparing a ceiling to a floor flatters the floor; this site compares maintenance to maintenance, which is the table above.

A way to feel the $60 monthly gap: over a year it funds 2.5 extra months at ShedRx’s own rate — the difference is not decoration, it is medication. Over two years it compounds to $1,440, which is the horizon at which structural details (prepaid ladders, membership drag, dose-tier repricing) start mattering more than the sticker itself.

Run the same two programs on the committed basis: ShedRx $289/mo month-to-month against TrimRx $349/mo month-to-month. The order holds: ShedRx leads on both readings, so plan structure sharpens the verdict here rather than reversing it. Whichever basis fits your commitment level, the upfront totals above are the honest units.

§ The clock, run forward

Three, six, twelve, twenty-four months — best path each way

3 months: ShedRx $867 monthly; TrimRx $1,047 monthly — best path favors ShedRx by $180. 6 months: ShedRx $1,734 monthly; TrimRx $2,094 monthly — best path favors ShedRx by $360. 12 months: ShedRx $3,468 monthly; TrimRx $4,188 monthly — best path favors ShedRx by $720. 24 months: ShedRx $6,936 monthly; TrimRx $8,376 monthly — best path favors ShedRx by $1,440.

Prepaid paths above are billed upfront and assume the published rate holds (the 24-month figures extend the 12-month rate, an assumption worth naming). The honest reading: over short horizons the monthly gap decides; over long horizons the prepaid ladders and structural traps (dose tiers, memberships) take over — which is exactly the split the verdict section below scores.

The same clock, on semaglutide

3 mo: ShedRx $747 vs TrimRx $897 — $150 to ShedRx. 6 mo: ShedRx $1,494 vs TrimRx $1,794 — $300 to ShedRx. 12 mo: ShedRx $2,988 vs TrimRx $3,588 — $600 to ShedRx. 24 mo: ShedRx $5,976 vs TrimRx $7,176 — $1,200 to ShedRx.

Same rules as above: prepaid figures are upfront commitments, and the 24-month lines extend the 12-month rate as a stated assumption. Where the two molecules crown different winners between these two programs, that split is itself the finding — molecule choice and provider choice are separate decisions.

§ Structure vs structure

Everything besides the price

Coverage: ShedRx publishes “not published”; TrimRx publishes “not published” — for anything short of an explicit 50-state claim, intake is the final word.

Neither names its pharmacy publicly — the single most useful disclosure in this category, missing on both sides; ask each, in writing, before paying either.

Exit terms: ShedRx — none month-to-month; 72-hour notice before the next billing cycle. TrimRx — none month-to-month; check terms before prepaying.

Evidence: ShedRx source-verified (captured 2026-08-05); TrimRx source-verified (2026-08-05).

The pattern worth internalizing: in this market, structural honesty and price honesty travel together. Programs that publish pharmacies and state lists tend to publish real maintenance prices; programs that hide one usually hide the other.

In the full tirzepatide index these two sit at #5 and #11 of 17: between them lie 5 other programs, and the whole ladder is at cheapest tirzepatide providers. In the full semaglutide index these two sit at #13 and #17 of 20: between them lie 3 other programs, and the whole ladder is at cheapest semaglutide providers.

§ If you move

Switching between ShedRx and TrimRx

Prescriptions do not transfer like phone numbers: moving in either direction means completing the destination’s intake and having its prescriber write a new patient-specific prescription. The mechanics that prevent a bad month: confirm the destination serves your state and quotes your current dose in writing before cancelling anything; time the first new shipment to overlap the last old one rather than gap it; cancel the origin per its published terms (ShedRx: 72-hour notice before the next billing cycle; TrimRx: check terms before prepaying) and screenshot the confirmation; and never leave a prepaid balance stranded — which is the standing argument for prepaying only after a program has already earned a few monthly cycles.

§ Verdict by situation

Which one, for whom

§ More pairings